X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA J.B.CHEMICALS ALEMBIC PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 26.3 14.0 188.1% View Chart
P/BV x 6.0 2.2 271.4% View Chart
Dividend Yield % 0.8 0.2 447.8%  

Financials

 ALEMBIC PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
J.B.CHEMICALS
Mar-16
ALEMBIC PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs792318 248.9%   
Low Rs443200 222.1%   
Sales per share (Unadj.) Rs167.0148.0 112.9%  
Earnings per share (Unadj.) Rs38.219.1 200.0%  
Cash flow per share (Unadj.) Rs42.023.9 175.4%  
Dividends per share (Unadj.) Rs4.000.50 800.0%  
Dividend yield (eoy) %0.60.2 335.4%  
Book value per share (Unadj.) Rs84.9128.9 65.8%  
Shares outstanding (eoy) m188.5284.82 222.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.71.7 211.3%   
Avg P/E ratio x16.213.6 119.3%  
P/CF ratio (eoy) x14.710.8 136.0%  
Price / Book Value ratio x7.32.0 362.3%  
Dividend payout %10.52.6 400.1%   
Avg Mkt Cap Rs m116,38321,951 530.2%   
No. of employees `000NA2.7 0.0%   
Total wages/salary Rs m4,2141,841 228.9%   
Avg. sales/employee Rs ThNM4,590.9-  
Avg. wages/employee Rs ThNM673.4-  
Avg. net profit/employee Rs ThNM592.1-  
INCOME DATA
Net Sales Rs m31,48712,551 250.9%  
Other income Rs m55542 10.2%   
Total revenues Rs m31,54213,093 240.9%   
Gross profit Rs m10,0602,055 489.6%  
Depreciation Rs m722412 175.1%   
Interest Rs m3796 38.5%   
Profit before tax Rs m9,3562,088 448.0%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,160469 460.5%   
Profit after tax Rs m7,1941,619 444.4%  
Gross profit margin %31.916.4 195.2%  
Effective tax rate %23.122.5 102.8%   
Net profit margin %22.812.9 177.2%  
BALANCE SHEET DATA
Current assets Rs m15,0667,778 193.7%   
Current liabilities Rs m7,6744,358 176.1%   
Net working cap to sales %23.527.2 86.2%  
Current ratio x2.01.8 110.0%  
Inventory Days Days6755 122.5%  
Debtors Days Days4180 50.8%  
Net fixed assets Rs m8,2375,713 144.2%   
Share capital Rs m377170 222.3%   
"Free" reserves Rs m15,41610,547 146.2%   
Net worth Rs m16,00510,937 146.3%   
Long term debt Rs m00-   
Total assets Rs m24,59415,574 157.9%  
Interest coverage x255.222.8 1,118.5%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.8 158.9%   
Return on assets %29.411.0 267.1%  
Return on equity %44.914.8 303.7%  
Return on capital %58.720.0 293.9%  
Exports to sales %55.748.7 114.4%   
Imports to sales %10.47.1 147.3%   
Exports (fob) Rs m17,5516,115 287.0%   
Imports (cif) Rs m3,283889 369.4%   
Fx inflow Rs m17,8116,169 288.7%   
Fx outflow Rs m5,3181,285 413.8%   
Net fx Rs m12,4934,884 255.8%   
CASH FLOW
From Operations Rs m9,3041,397 666.1%  
From Investments Rs m-3,105-320 969.3%  
From Financial Activity Rs m-1,959-1,196 163.8%  
Net Cashflow Rs m4,240-102 -4,144.7%  

Share Holding

Indian Promoters % 74.1 55.4 133.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 2.9 3.4 85.5%  
FIIs % 9.1 3.9 233.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 37.0 37.6%  
Shareholders   49,328 30,437 162.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 200 Points Higher; Lupin & Axis Bank Top Gainers(09:30 am)

Majority of Asian stock indices are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.07%, while the Hang Seng is up 1.06%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 22, 2017 11:40 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS